GHB04L1

BIOLOGICAL2 trials

Sponsors

AVIR Green Hills Biotechnology AG

Conditions

InfluenzaInfluenza, Avian

Phase 1

Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults

CompletedNCT00741806

AVIR Green Hills Biotechnology AGInfluenza

Start: 2008-08-31End: 2010-03-31Updated: 2010-03-02

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

CompletedNCT03745274

AVIR Green Hills Biotechnology AGInfluenza, Avian

Start: 2008-12-19End: 2009-05-27Updated: 2018-11-20

Related Papers

Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.

2019-05-3021 citations